Cargando…
Spironolactone Reduces Severity of Obstructive Sleep Apnea in Patients with Resistant Hypertension: a Preliminary Report
INTRODUCTION: Obstructive sleep apnea (OSA) and hyperaldosteronism are very common in subjects with resistant hypertension. We hypothesized that aldosterone mediated chronic fluid retention may influence OSA severity in patients with resistant hypertension. We tested this in an open label evaluation...
Autores principales: | Gaddam, Krishna, Pimenta, Eduardo, Thomas, S. Justin, Cofield, Stacey S, Oparil, Suzanne, Harding, Susan M., Calhoun, David A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891919/ https://www.ncbi.nlm.nih.gov/pubmed/20016520 http://dx.doi.org/10.1038/jhh.2009.96 |
Ejemplares similares
-
Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change
por: Aryal, Sudeep R., et al.
Publicado: (2021) -
Hypertension and obstructive sleep apnea
por: Phillips, Craig L, et al.
Publicado: (2013) -
Obstructive Sleep Apnea in Hypertension
por: Chaudhary, Shyam C, et al.
Publicado: (2023) -
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009) -
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)